1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow FlowOx2.0 (Sham): new trials by email Literature Review of FlowOx2.0 (Sham) trials Research Report on FlowOx2.0 (Sham)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain FlowOx 2.0, FlowOx2.0 (Sham) - Multiple Sclerosis, Spasticity, Muscle | Not applicable | Completed | Otivio AS | 56 | 2022-10-04 | 2026-10-19 |
Chronic Pain (1) · Multiple Sclerosis (1) · Muscle Spasticity (1)
Otivio AS (1)
Sweden (1)
Kjell-Morten Myhr, MD, PhD (1) · Peter Vestergaard Rasmussen, MD, PhD (1) · Sara Haghighi Mobarhan Smith, MD, PhD (1)